Advertisement

What is Strensiq?

Strensiq is an injectable drug precribed for the treatment of perinatal/infantile- and juvenile-onset hypophosphatasia. This rare and inherited metabolic disorder causes bone demineralization, rickets, and bone softening in children, along with complications like weakness, seizures, pain, and even death. Strensiq (asfotase alfa) replaces the enzyme missing in these patients and helps lead to normal bone development, improving survival rates in the first year dramatically. It is given as an injection three to six times a week. Side effects include sensitivity reactions (nausea, breathing problems, fever), injection site reactions (pain, redness/discoloration, itching, etc.), and calcium deposits in the kidneys or eyes. Patients are monitored closely for these adverse reactions. 

Continue Learning about Research & Treatment Innovations

How are gangliosidoses treated?
Piedmont Heart InstitutePiedmont Heart Institute
No specific treatment exists for the gangliosidoses. Anticonvulsants may initially control seizures....
More Answers
What are the benefits of metabolic surgery?
Dr. Keith A. Kreitz, MDDr. Keith A. Kreitz, MD
The benefits of metabolic surgery include weight loss that leads to remission in health problems. Do...
More Answers
What Causes Public Efforts to AId In Treatment Research?
What Causes Public Efforts to AId In Treatment Research?
Why is It Important to Understand Genetics?
Why is It Important to Understand Genetics?

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.